Article
New York-Glaucoma therapy of 10 years ago has no application today, according to Robert D. Fechtner, MD, who opened a session on glaucoma and cataract surgery at the Glaucoma 2002 meeting here.
A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lwey
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Women’s eye health: The Fred Hollows Foundation's call for change this International Women’s Day
Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus
Australian Society of Ophthalmologists announces new board appointments
Cleveland Clinic’s Cole Eye Institute expands with Jeffrey and Patricia Cole Pavilion